Sign in
4/A

Changes in Ownership

Coherus Oncology, Inc. Filed Acc 0000899243-16-021027

Options or other derivatives

  • Director bought 1,000,000 shares at $22.35 ($22,350,000)

From the SEC's structured data for this filing

Trades in this filing

Wahlstrom Mats · Director

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2016-02-29 Purchase : show line 1 in the form 8.2% Senior Convertible Notes due 2022 +1,000,000 $22.35 $22,350,000 1,000,000 I
Loading xslF345X03/doc4a.xml…